Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juniperus pinchotii pollen is an allergenic extract derived from the pollen of Juniperus pinchotii (Pinchot's juniper or redberry juniper), a plant species native to parts of North America. It is primarily used in allergy testing and diagnosis to identify sensitivity to this specific type of tree pollen. The extract works by exposing the immune system to small amounts of the allergen, which can help determine allergic responses in patients suspected of having seasonal or environmental allergies related to this plant. Its mechanism involves triggering an IgE-mediated immune response typical for type I hypersensitivity reactions[1][2][4]. There are no known pharmaceutical developers; it is classified as a structurally diverse natural product sourced from plants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Juniperus pinchotii pollen.